tradingkey.logo
搜索

TScan Therapeutics Inc

TCRX
添加自选
0.743USD
-0.013-1.68%
收盘 07-31 16:00美东报价延迟15分钟
42.28M总市值
亏损市盈率 TTM

TCRX 财务数据

通过专为投资者打造的一站式数据看板,全面查看 TScan Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

TScan Therapeutics Inc财报日历

最新发布
5月 6, 2026
每股收益 / 预测值
-0.22/-0.17
营业收入 / 预测值
982.00K/2.50M
报告期
FY2025 财报
营业收入(YoY)
10.32M
266.65%
每股收益(YoY)
-1.00
12.17%
分析师评级
BUY
2026/08/01
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
16.16%-0.22
40.29%-0.18
-9.23%-0.28
-2.04%-0.28
17.16%-0.26
-43.92%-0.30
-3.83%-0.25
45.19%-0.28
65.89%-0.32
73.52%-0.21
---0.24
---0.51
---0.93
---0.78
---1.98
----
----
----
----
----
营业收入
-54.77%982.00K
286.02%2.57M
139.37%2.51M
473.88%3.08M
283.57%2.17M
-90.78%665.00K
-73.01%1.05M
-82.97%536.00K
-91.68%566.00K
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.80M
8.44%3.10M
39.43%3.36M
42.42%4.06M
49.04%3.02M
258.99%2.85M
731.72%2.41M
--2.85M
净利润
16.00%-28.67M
35.83%-22.98M
-19.48%-35.71M
-16.71%-36.95M
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
利润率
-85.70%-2919.14%
83.38%-895.09%
50.08%-1422.14%
79.66%-1201.30%
70.48%-1571.95%
-1879.80%-5384.81%
-381.56%-2849.09%
-673.34%-5906.90%
-1505.68%-5325.44%
55.04%-271.99%
---591.64%
---763.82%
---331.66%
---604.94%
---454.96%
----
----
----
----
----
毛利率
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
资产负债率
67.13%16.17%
64.55%14.22%
40.37%12.36%
33.18%10.82%
-22.98%9.67%
-21.73%8.64%
-14.31%8.81%
-13.39%8.12%
-26.11%12.56%
-24.95%11.04%
--10.28%
--9.38%
--17.00%
--14.71%
--17.57%
----
----
----
----
----
营业收入
-54.77%982.00K
286.02%2.57M
139.37%2.51M
473.88%3.08M
283.57%2.17M
-90.78%665.00K
-73.01%1.05M
-82.97%536.00K
-91.68%566.00K
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.80M
8.44%3.10M
39.43%3.36M
42.42%4.06M
49.04%3.02M
258.99%2.85M
731.72%2.41M
--2.85M
营业利润
19.62%-29.14M
40.46%-21.86M
-13.58%-37.05M
-13.31%-38.65M
-15.55%-36.25M
-71.90%-36.71M
-31.82%-32.62M
-38.62%-34.11M
-37.95%-31.37M
-14.52%-21.36M
-49.28%-24.75M
-61.42%-24.61M
-40.71%-22.74M
-31.31%-18.65M
-4.65%-16.58M
-42.77%-15.25M
-104.13%-16.16M
-81.84%-14.20M
-120.92%-15.84M
-90.15%-10.68M
净利润
16.00%-28.67M
35.83%-22.98M
-19.48%-35.71M
-16.71%-36.95M
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
流动资产
-47.90%132.77M
-46.29%157.21M
-31.35%188.16M
-26.17%221.13M
54.71%254.84M
50.70%292.72M
25.98%274.08M
23.66%299.53M
63.24%164.72M
56.48%194.24M
54.11%217.57M
87.24%242.22M
-30.77%100.91M
-25.07%124.13M
-24.51%141.18M
17.53%129.36M
17.66%145.75M
--165.65M
--187.00M
--110.07M
流动负债总额
-33.02%19.97M
-48.01%18.70M
1.91%29.21M
-18.80%31.32M
-5.28%29.82M
20.58%35.96M
-13.55%28.66M
9.84%38.57M
124.10%31.48M
72.32%29.82M
99.78%33.15M
104.53%35.12M
-23.93%14.05M
-18.92%17.30M
-27.68%16.59M
-16.72%17.17M
-1.98%18.46M
--21.34M
--22.94M
--20.62M
总资产
-39.29%201.99M
-38.35%228.79M
-24.65%262.23M
-20.36%298.56M
38.15%332.71M
36.37%371.12M
19.44%348.03M
18.28%374.87M
38.75%240.83M
36.70%272.15M
76.11%291.38M
107.93%316.92M
3.19%173.58M
5.84%199.09M
-19.25%165.45M
17.24%152.41M
19.34%168.20M
--188.11M
--204.89M
--130.01M
总负债
-14.23%105.07M
-18.81%105.67M
-0.62%118.20M
1.84%121.85M
3.94%122.51M
7.31%130.15M
-2.84%118.94M
-5.28%119.65M
23.34%117.86M
21.70%121.28M
150.88%122.42M
508.37%126.32M
324.52%95.56M
264.66%99.66M
58.35%48.80M
-32.20%20.76M
-28.43%22.51M
--27.33M
--30.82M
--30.63M
总权益
-53.89%96.92M
-48.91%123.12M
-37.13%144.02M
-30.76%176.71M
70.94%210.20M
59.72%240.97M
35.59%229.09M
33.90%255.22M
57.61%122.97M
51.73%150.87M
44.83%168.96M
44.78%190.61M
-46.45%78.02M
-38.15%99.43M
-32.98%116.66M
32.47%131.65M
33.07%145.69M
--160.78M
--174.07M
--99.38M
经营净额
35.40%-24.28M
-16.74%-32.00M
-16.28%-32.46M
-26.85%-33.27M
-28.42%-37.59M
-15.34%-27.41M
-448.24%-27.92M
-19.09%-26.23M
-24.08%-29.27M
-48.44%-23.77M
147.15%8.02M
-64.75%-22.02M
-17.21%-23.59M
-11.34%-16.01M
-24.65%-17.00M
-24.93%-13.37M
-102.11%-20.12M
-95.65%-14.38M
-135.62%-13.64M
-170.19%-10.70M
投资净额
-100.52%-70.00K
-45.67%14.83M
139.56%32.58M
243.66%48.44M
-62.59%13.53M
1326.71%27.29M
-34.09%-82.35M
-7927.62%-33.72M
4415.39%36.16M
238.93%1.91M
-14384.43%-61.41M
77.81%-420.00K
-57.82%-838.00K
37.72%-1.38M
50.29%-424.00K
51.68%-1.89M
82.05%-531.00K
-59.64%-2.21M
36.49%-853.00K
-1113.00%-3.92M
融资净额
100.00%0.00
-99.84%73.00K
-100.00%0.00
-99.93%116.00K
-303.49%-525.00K
240373.68%45.69M
588.10%1.23M
19.10%161.59M
--258.00K
-82.41%19.00K
-100.87%-252.00K
437564.52%135.68M
-100.00%0.00
-10.00%108.00K
-67.85%29.13M
104.52%31.00K
-99.91%88.00K
200.00%120.00K
9060700.00%90.61M
-2738.46%-686.00K

常见问题

TScan Therapeutics Inc的总收入是多少?

根据TScan Therapeutics Inc的FY2025财报,总收入达到了10.32M(同比变化2.82M)。

TScan Therapeutics Inc的流动资产是多少?

根据TScan Therapeutics Inc的FY2025财报,流动资产为157.21M(同比变化-46.29)。

TScan Therapeutics Inc的总资产是多少?

根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的总资产为228.79M(同比变化-38.35)。

TScan Therapeutics Inc的总负债是多少?

根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的总负债为105.67M(同比变化-18.81)。

TScan Therapeutics Inc的总权益是多少?

根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的总权益为123.12M(同比变化-48.91)。

TScan Therapeutics Inc的净营业收入是多少?

根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的净营业收入为-133.81M(同比变化0.75)。

TScan Therapeutics Inc的净投资是多少?

根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的净投资为109.37M(同比变化307.88)。

TScan Therapeutics Inc的净融资是多少?

根据TScan Therapeutics Inc的FY2025财报,TScan Therapeutics Inc的净融资为-336.00K(同比变化-100.16)。

TScan Therapeutics Inc的每股收益(EPS)是多少?

根据TScan Therapeutics Inc的FY2025财报,每股收益(EPS)为-1.00(同比变化12.17)。

TScan Therapeutics Inc的净利润是多少?

根据TScan Therapeutics Inc的FY2025财报,净利润为-129.77M(同比变化-1.78)。

TScan Therapeutics Inc的净利润率是多少?

根据TScan Therapeutics Inc的FY2025财报,净利润率为-1256.81(同比变化72.24)。

TScan Therapeutics Inc的债务与资产比率是多少?

根据TScan Therapeutics Inc的FY2025财报,债务与资产比率为14.22(同比变化64.55)。

TScan Therapeutics Inc的股东权益回报率(ROE)是多少?

根据TScan Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-71.28(同比变化-9.53)。

TScan Therapeutics Inc的资产回报率(ROA)是多少?

根据TScan Therapeutics Inc的FY2025财报,资产回报率(ROA)为-43.26(同比变化-9.13)。

TScan Therapeutics Inc的营业利润是多少?

根据TScan Therapeutics Inc的FY2025财报,营业利润为-133.81M(同比变化0.75)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有